Life Technologies reported $74.66M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Ardelyx USD 139.53M 33.76M Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
Bristol-Myers Squibb USD 17.49B 100M Jun/2025
Cipla INR 311.93B 27.38B Mar/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 50.26M 4.65M Jun/2025
CSL USD 20.55B 3.18B Dec/2024
Galapagos EUR 2.64B 104.07M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
Grifols EUR 5.88B 533.83M Dec/2024
Life Technologies USD 74.66M 4.64M Jun/2025
Novartis USD 42.05B 3.6B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
United Therapeutics USD 7.17B 366.4M Jun/2025